PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
09-Jun-2022 Creative Diagnostics Introduces CC50/IC50 Assay Services for Pharmaceutical Safety Creative Diagnostics
09-Jun-2022 STEMart Launches Microbiology & Sterility Testing Services for Medical Devices STEMart
09-Jun-2022 Amerigo Scientific Announces the Launch of Extra Large Drying Traps Amerigo Scientific
09-Jun-2022 New AMPK Pathways Offered to Support Metabolism Research CD BioSciences
09-Jun-2022 Creative Diagnostics Launches Measles Virus Antigens for the Detection of Antibodies Creative Diagnostics
09-Jun-2022 CD BioSciences Announces Solubilization and Stabilization Solution to Simplify GPCR Research CD BioSciences
09-Jun-2022 Alnylam Awarded Innovation Passport in the United Kingdom for Zilebesiran, an Investigational RNAi Therapeutic for the Treatment of Hypertension Alnylam Pharmaceuticals
08-Jun-2022 Lead Pharma and Oxeltis receive €800K EUREKA Eurostars grant  Andrew Lloyd Associates
08-Jun-2022 FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older Novavax
08-Jun-2022 ProteoGenix, Aseem Healthcare, and Trident Biopharm Solutions Announce a New Antibody Cocktail Effective Against Major Variants of SARS-CoV-2 ProteoGenix
08-Jun-2022 Nosopharm and GNA Now announce positive results for the late preclinical development of the first-in-class antibiotic NOSO-502 Andrew Lloyd Associates
07-Jun-2022 Integrated DNA Technologies, Beckman Coulter Life Sciences Ink Distribution Deal Integrated DNA Technologies (IDT)
07-Jun-2022 CYTENA Enters Long Term OEM Supply Agreement with PAIA and Launches the F.QUANT Titer, High-Throughput Titer Quantification Assays for Antibodies and Fc Fusion Proteins CYTENA
07-Jun-2022 Immutep reports positive Overall Response Rate in its Phase II clinical trial in first line NSCLC for PD-L1 all-comers Immutep
07-Jun-2022 Major shareholder announcement for Genmab A/S Genmab
07-Jun-2022 Lynred launches two multispectral linear array infrared detectors for future Earth observation mission applications Andrew Lloyd Associates
07-Jun-2022 ImmunOs Therapeutics Raises $74 Million Series B Financing Round ImmunOs Therapeutics
06-Jun-2022 CD Formulation Offers Forced Degradation Studies CD Formulation
02-Jun-2022 Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies Boehringer Ingelheim / A*STAR
02-Jun-2022 MedExecWomen Third Annual Conference in Boston, June 14, 2022 SCORR Marketing